The application of non-steroidal anti-inflammatory drugs (NSAIDs) such as indometacin or diclofenac to prevent post-ERCP pancreatitis (PEP) has been examined in several randomized trials throughout
pancreatitis prophylaxis
pancreatitis prophylaxis
ERCP | Literature | Pancreas